The downregulation of CYP3A4 expression was also observed in HCV and ALD, but not in PSC and NAFLD, whereas CYP2C9 showed no significant changes in the abovementioned pathologies [8, 22]. This evidence concerns the gene CYP3A4 and metabolic dysfunction-associated steatotic liver disease.